
    
      In this single site clinical trial, intended to evaluate the safety and efficacy of repeated
      doses of ketamine in conjunction with prolonged exposure (PE) therapy for PTSD. Veterans who
      meet criteria for PTSD and the additional inclusion and exclusion criteria will be randomized
      to one of two treatment arms (placebo plus PE vs ketamine plus PE). Participants receive the
      study drug via intravenous infusion once per week for 3-weeks.
    
  